ARTERRA BIOSCIENCE
Milan Stock Exchange ARBS.MI
ARTERRA BIOSCIENCE Free Cash Flow for the year ending December 31, 2023: USD 1.04 M
ARTERRA BIOSCIENCE Free Cash Flow is USD 1.04 M for the year ending December 31, 2023, a -24.95% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
ARTERRA BIOSCIENCE Free Cash Flow for the year ending December 31, 2022 was USD 1.39 M, a 54.67% change year over year.
-
ARTERRA BIOSCIENCE Free Cash Flow for the year ending December 31, 2021 was USD 896.84 K, a 654.56% change year over year.
-
ARTERRA BIOSCIENCE Free Cash Flow for the year ending December 31, 2020 was USD 118.86 K, a -17.69% change year over year.
-
ARTERRA BIOSCIENCE Free Cash Flow for the year ending December 31, 2019 was USD 144.41 K, a -69.71% change year over year.
Key data
| Date | Free Cash Flow | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Market news
Loading...
Milan Stock Exchange: ARBS.MI
| CEO | Ms. Maria Gabriella Colucci |
| IPO Date | Oct. 28, 2019 |
| Location | Italy |
| Headquarters | via Benedetto Brin, 69 Napoli, 80142Italy |
| Employees | 34 |
| Sector | Health Care |
| Industries | |
Description
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email